
Kedalion raises $5M in Series A round for topical eye drug delivery product
Company raises $5 million from Lagunita Biosciences for technology to improve eye drug administration.
Company raises $5 million from Lagunita Biosciences for technology to improve eye drug administration.
Drug delivery may not mean swallowing a pill or getting a shot anymore. From dissolvable wafers to micro-robots, drug delivery is changing for the better.
MedCity News has partnered with BioCrossroads to provide coverage focused on Indiana’s next generation of growth and innovation in life sciences Purdue University spinout Biokorf is developing a new way to manufacture pharmaceuticals, attempting to personalize drug dosage and delivery methods. It’s certainly an interesting endeavor in this era of precision medicine. Chief Scientific Officer Rodolfo Pinal put the use-case […]